Snowball logo
logo
CYTO

CYTOF

CYTOF • OTCQB
$0.10+$0.031  (44.93%)
Estimate
EPS
-1.19
Beta
2.782
About the company
Ticker
CYTOF
ISIN
Country
Bermuda
Sector (GICS)
Other
Altamira Therapeutics Ltd. operates as a preclinical-stage biopharmaceutical company in Switzerland, Australia, the United States, and Europe. The company develops and supplies peptide-based nanoparticle technologies for efficient RNA delivery to extrahepatic tissues through xPhore platform; and offers Bentrio, a drug-free nasal spray for protection against airborne viruses and allergens It is also developing AM-401 for the treatment of KRAS driven cancer; AM-411 for the treatment of rheumatoid arthritis; and AM-125 that is in post phase II clinical trial for the intranasal treatment of vertigo. The company was formerly known as Auris Medical Holding Ltd. and changed its name to Altamira Therapeutics Ltd. in July 2021. The company was founded in 2003 and is based in Hamilton, Bermuda.

Frequently asked questions

What sector does CYTOF (CYTOF) operate in?

CYTOF belongs to the Other sector and operates in the Biotechnology industry.

What is CYTOF (CYTOF) current stock price?

As of the latest data, CYTOF stock price is $0.10, with a previous close of $0.07. CYTOF gained $0.03 in the last trading session, representing a 44.93% increase.

What is CYTOF (CYTOF) current market capitalization?

CYTOF market cap is approximately 571.55 thousand.

What is CYTOF (CYTOF) Earnings Per Share (EPS)?

The trailing EPS is -$1.19.

Does CYTOF (CYTOF) pay dividends?

No. CYTOF does not pay a dividend.

What is CYTOF (CYTOF) beta (volatility) score?

CYTOF has a beta of 2.782, indicating very high volatility compared to the market.